Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series

Christine M Yost; Amos S Gaikwad; D Williams Parsons; Karen R Rabin; Vincent U Gant; Kevin E Fisher; Andrea N Marcogliese; Eric S Schafer

doi:10.1080/10428194.2020.1815018

Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series

Leuk Lymphoma. 2020 Dec;61(14):3515-3518. doi: 10.1080/10428194.2020.1815018. Epub 2020 Sep 2.

Authors

Christine M Yost^{1

2}, Amos S Gaikwad^{1

2}, D Williams Parsons^{1

2}, Karen R Rabin^{1

2}, Vincent U Gant^{1

2}, Kevin E Fisher^{2

3}, Andrea N Marcogliese^{1

2

3}, Eric S Schafer^{1

2}

Affiliations

¹ Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
² Texas Children's Cancer and Hematology Centers, Houston, TX, USA.
³ Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.

PMID: 32876512
DOI: 10.1080/10428194.2020.1815018

No abstract available

Publication types

Letter

MeSH terms

Gene Rearrangement
Humans
Leukemia* / diagnosis
Leukemia* / genetics
Myeloid-Lymphoid Leukemia Protein* / genetics

Substances

Myeloid-Lymphoid Leukemia Protein